CQDM is currently looking for a Communications Specialist to join its team in Montréal. This role focuses on developing impactful communications that highlight innovation, collaboration, and the impact of CQDM’s initiatives across the life sciences ecosystem. The selected candidate will contribute to the organization’s visibility through strategic communication planning, compelling storytelling, content creation, and stakeholder…
CQDM is joining forces with leaders across Canada’s life sciences ecosystem to reaffirm the importance of fostering an environment that supports innovation, growth, and the commercialization of research-driven breakthroughs. At CQDM, we believe that collaboration is one of Canada’s greatest competitive advantages.This joint call from leaders across the country’s life sciences ecosystem highlights the importance…
How does a young Canadian biotech transform a promising technology into a tangible growth opportunity? The answer lies in the story of Variational AI, a company that is reaching a significant milestone in its growth journey through a strategic partnership with Merck, made possible with the support of CQDM. At the heart of this collaboration…
Announcement Montreal, July 7, 2026 – CQDM and IVADO are proud to announce the funding of a collaborative research project aimed at developing a predictive artificial intelligence (AI) system in oncology, powered by cutting-edge phenotypic data. Valued at over $2.2 million, the project is supported by a $1,101,390 grant from the Government of Québec. This…
On the sidelines of BIO 2026, CQDM and Investissement Québec International brought together more than 100 life sciences stakeholders for a reverse pitch session aimed at accelerating biopharmaceutical R&D collaborations. A format designed to align industry needs with innovation The reverse pitch format enables large pharmaceutical companies to present their priorities and R&D needs directly…
Announcement San Diego, California, June 22, 2026 – CQDM welcomes this new contribution of nearly $11 million granted by the Government of Québec to AReNA, Québec’s RNA Hub, a flagship initiative under the Stratégie québécoise des sciences de la vie (SQSV). This funding will enable this high-impact initiative to continue and expand its activities, while…
Announcement Montréal, Québec, June 18, 2026 – CQDM is proud to announce the funding of six collaborative R&D projects, representing a total investment of $10,173,321. These projects lie at the very core of CQDM’s mission: to intervene at the highest risk stages of biopharmaceutical innovation, where scientific uncertainty is greatest and access to funding often…
CQDM is pleased to launch a call for ideas for the upcoming CQDM Connect-Pharma: Pitch Day, focused on next-generation immunotherapies. Selected applicants will present their innovations to experts from CQDM’s global pharmaceutical members on September 16, 2026. Our objective is to bring ground-breaking, innovative Canadian research to CQDM’s pharmaceutical members and facilitate interactions between our…
Kim Fredricks joined CQDM in June 2026 as Director of programs. With nearly 15 years of experience in the healthcare network and community sector, she brings expertise in project management, quality, risk management, governance, and change support. Driven by a strong interest in life sciences, health, and innovation, she puts her experience to work in…
CQDM is currently looking for an Innovation Advisor to join its team in Montréal. This role focuses on connecting science, industry, and talent to turn ideas into high-impact, collaborative projects. The selected candidate will actively contribute to shaping and structuring strategic initiatives within the biopharmaceutical ecosystem.